Intrathecal chemotherapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Intrathecal chemotherapy, covering 2024-05-28 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study [NA]